Loading
Yanuki
SUBCATEGORY FEED
ImmunityBio's Anktiva: Asian Expansion and NCCN Guideline Inclusion | ImmunityBio Advances NMIBC Program with Positive ANKTIVA® Data | ImmunityBio's Anktiva: Asian Expansion and NCCN Guideline Inclusion | ImmunityBio Advances NMIBC Program with Positive ANKTIVA® Data

Health / Cancer Treatment

ImmunityBio's Anktiva: Asian Expansion and NCCN Guideline Inclusion

ImmunityBio's Anktiva (nogapendekin alfa inbakicept-pmln) is making significant strides in bladder cancer treatment. Recently, it secured approval in Macau, marking its expansion into Asia, and was added to the National Comprehensive Cancer...

ImmunityBio's Anktiva: Asian Expansion and NCCN Guideline Inclusion Image via Yahoo Finance
ImmunityBio (IBRX) Soars 11% as Asian Expansion Looms
Vaccines Infectious Diseases Public Health Wellness Weight Loss Cancer Nutrition Policy Celebrity Health Mental Health